Endoca Revenue and Competitors
Estimated Revenue & Valuation
- Endoca's estimated annual revenue is currently $5.8M per year.
- Endoca's estimated revenue per employee is $233,160
Employee Data
- Endoca has 25 Employees.
- Endoca grew their employee count by 0% last year.
Endoca Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $113.2M | 465 | -3% | N/A | N/A |
#2 | $80M | 398 | 18% | N/A | N/A |
#3 | $29.3M | 155 | 23% | N/A | N/A |
#4 | $5.8M | 25 | 0% | N/A | N/A |
#5 | $43.2M | 178 | 3% | N/A | N/A |
#6 | $10.9M | 45 | 2% | N/A | N/A |
#7 | $5.6M | 35 | 59% | N/A | N/A |
#8 | $17.1M | 109 | 60% | N/A | N/A |
What Is Endoca?
At Endoca our primary focus is to research and develop innovative Hemp extracts and to make them accessible world-wide. We are dedicated to producing the finest and purest quality CBD oil while never compromising on quality. Our primary goal is to develop different high quality Hemp extracts with broad profile of cannabinoids and other natural molecules found in Hemp and to identify their distinct properties.
keywords:N/AN/A
Total Funding
25
Number of Employees
$5.8M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Endoca News
ENDOCA, Cannoid, LLC, Medical Marijuana, Inc., Folium Biosciences, Elixinol, NuLeaf Naturals, LLC, Isodiol International, Inc. and...
Aurora Cannabis, ENDOCA, Medical Marijuana, CBD American Shaman, NuLeaf Naturals, Folium Biosciences, Gaia Herbs, Canopy Growth Corporation,...
Some of the Top companies Influencing in this Market include: ENDOCA, CBD American Shaman, Gaia Botanicals, Isodiol, Medical Marijuana,...
Some of the key players profiled in the study are ENDOCA, Isodiol, Medical Marijuana, Aurora Cannabis, CBD American Shaman, Elixinol,
The key companies are mentioned here ENDOCA, Gaia Botanicals, Isodiol, Medical Marijuana, Aurora Cannabis (AC), Cannoid, CBD
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.1M | 25 | 4% | N/A |
#2 | $2.6M | 25 | 67% | N/A |
#3 | $2.6M | 25 | N/A | N/A |
#4 | $2M | 27 | 59% | $3M |
#5 | $15M | 27 | 8% | N/A |